Guggenheim initiates Mercury Systems stock with buy on defense trends

Guggenheim initiated Mercury Systems with a Buy rating and $115 price target, implying 42% upside from the $81.03 share price; consensus targets imply roughly 45% upside. The firm expects defense-modernization demand, recent booking momentum and backlog growth to drive accelerating revenue and margin expansion through fiscal 2028. Mercury's fiscal Q4 2026 revenue reached a record $289.8 million, up 6.1% organically, while adjusted EPS of $0.37 narrowly missed the $0.38 consensus; bookings rose 93.1% and backlog increased 38.4% to $1.945 billion.

Analysis

MRCY’s investable question is no longer demand visibility; it is whether the company can convert backlog into higher-quality revenue without repeating the execution, inventory, and program-cost leakage that impaired prior margins. The equity should re-rate only if incremental gross margin and free-cash-flow conversion improve alongside sales, rather than merely recognizing backlog. A one-cent quarterly EPS miss is immaterial; a second consecutive quarter of weak conversion against elevated bookings would signal that the bottleneck remains operational.

The second-order beneficiary of a successful turnaround is MRCY’s position as a non-prime supplier: greater procurement emphasis on secure domestic electronics can increase content per platform without requiring MRCY to win entire programs. Conversely, Curtiss-Wright (CW), Teledyne (TDY), L3Harris (LHX), and defense-prime internal electronics capabilities constrain pricing power; defense-budget strength alone does not ensure MRCY captures the margin upside. Higher long-duration Treasury yields are a near-term valuation headwind for a multi-year turnaround, making earnings execution—not additional target-price increases—the necessary catalyst.

Consensus appears to be pricing substantial upside already, so the favorable risk/reward is conditional on a clean next two reporting cycles. Over the next 1-3 months, watch for book-to-bill durability, backlog conversion, gross-margin progression, and any increase in working-capital needs. Over 6-18 months, the thesis is falsified if revenue growth accelerates but operating margin and cash conversion fail to improve, indicating that the backlog is lower-margin, cost-plus, or supply-chain constrained.

Key Decisions for Investors

• Initiate a starter long MRCY only in the $78-$83 range, sized as a turnaround position rather than a core defense holding. Target $105-$115 over 6-12 months if the next two quarters show organic growth plus gross-margin expansion; cut or reassess below $72, or immediately after a guidance reduction.
• Add to MRCY only after independently verifying quarterly book-to-bill above 1.0x, improving adjusted operating margin, and positive free-cash-flow conversion. Do not add solely on further sell-side target increases, which have limited incremental information value given already-bullish published expectations.
• For relative-value exposure, consider long MRCY / short CW in equal dollar amounts after MRCY confirms margin inflection. This isolates the potential turnaround re-rating from broad defense-budget beta; exit if MRCY’s operating-margin trajectory remains flat while CW continues to execute.
• Set an event alert for the next earnings release: a material inventory or receivables build, or backlog growth without corresponding revenue conversion, is the key bearish signal and would favor avoiding the long despite apparent order strength.